|
|
|
Volumn 23, Issue 10, 2002, Pages 517-519
|
|
Study on the biological activity and molecular mechanism of IFNalpha on human myeloma cell line Sko-007
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BCL2L1 PROTEIN, HUMAN;
GLYCOPROTEIN GP 130;
IL6ST PROTEIN, HUMAN;
INTERLEUKIN 6 RECEPTOR;
LEUKOCYTE ANTIGEN;
MEMBRANE PROTEIN;
MITOGEN ACTIVATED PROTEIN KINASE;
PROTEIN BCL 2;
PROTEIN BCL X;
ARTICLE;
CELL CULTURE;
CELL CYCLE;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CELL DIVISION;
DOSE RESPONSE;
DOWN REGULATION;
DRUG EFFECT;
ENZYME ACTIVATION;
HUMAN;
IMMUNOBLOTTING;
METABOLISM;
MULTIPLE MYELOMA;
PATHOLOGY;
ANTIGENS, CD;
BCL-X PROTEIN;
CELL CYCLE;
CELL DIVISION;
CYTOKINE RECEPTOR GP130;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOWN-REGULATION;
ENZYME ACTIVATION;
G0 PHASE;
G1 PHASE;
HUMANS;
IMMUNOBLOTTING;
INTERFERON-ALPHA;
MEMBRANE GLYCOPROTEINS;
MITOGEN-ACTIVATED PROTEIN KINASES;
MULTIPLE MYELOMA;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RECEPTORS, INTERLEUKIN-6;
S PHASE;
TUMOR CELLS, CULTURED;
|
|
EID: 1842846645
PISSN: 02532727
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
